PepTalk Keynote Presentations:

TUESDAY, JANUARY 19

Characterization of Biotherapeutics Carrying Synonymous Mutations

Chava Kimchi-Sarfaty, PhD, Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA


New Methods for Cell-Free Presentation of Proteins for Functional Analysis

Joshua LaBaer, PhD, Executive Director, Arizona State University Biodesign Institute


Rise of the Machines: Optimizing Workflows for Compatibility with Automation

Sarah M. Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation


Analysis of New Therapeutic Modalities: Challenges, Opportunities, and New Methods

Sunny Zhou, PhD, Professor, Chemistry & Chemical Biology, Northeastern University


WEDNESDAY, JANUARY 20

Chemically Generated Bispecific Antibodies: Strengths and Challenges

Changshou Gao, PhD, Senior Director & Fellow, Antibody Discovery & Protein Engineering, AstraZeneca Biologics


History and Application of Biological Standardisation to Biological Products, and Relevance to ATMP

Christopher Bravery, PhD, Consulting Regulatory Scientist, Consulting on Advanced Biologicals Ltd.


Continuous Precipitation – Microfiltration for Initial Purification of Monoclonal Antibodies

Andrew Zydney, PhD, Bayard D. Kunkle Chair & Professor, Chemical Engineering, Pennsylvania State University


THURSDAY, JANUARY 21

Structure and Characterization of Monoclonal Antibody Self-Association Complex Reveals Specific Face-to-Face Interaction: Developability and Predictive Implications

Carl Mieczkowski, PhD, Associate Principal Scientist, Protein Sciences, Merck Research Labs


Rise of the Machines: Optimizing Workflows for Compatibility with Automation

Sarah M. Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation